MA44634A1 - Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate - Google Patents

Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate

Info

Publication number
MA44634A1
MA44634A1 MA44634A MA44634A MA44634A1 MA 44634 A1 MA44634 A1 MA 44634A1 MA 44634 A MA44634 A MA 44634A MA 44634 A MA44634 A MA 44634A MA 44634 A1 MA44634 A1 MA 44634A1
Authority
MA
Morocco
Prior art keywords
quinuclidin
thiazol
propan
fluorophenyl
salt forms
Prior art date
Application number
MA44634A
Other languages
English (en)
Inventor
Craig Siegel
Jin Zhao
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Priority claimed from PCT/US2014/027081 external-priority patent/WO2014152215A1/fr
Publication of MA44634A1 publication Critical patent/MA44634A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes de sels de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate utiles en tant qu'un inhibiteur de synthase de glucosylcéramide (gcs) et pour le traitement de maladies métaboliques telles que les maladies lysosomales, soit seul, soit en association avec une thérapie de remplacement enzymatique, et pour le traitement du cancer.
MA44634A 2014-03-14 2014-03-14 Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate MA44634A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2014/027081 WO2014152215A1 (fr) 2013-03-15 2014-03-14 Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate
US201561791706P 2015-03-15 2015-03-15

Publications (1)

Publication Number Publication Date
MA44634A1 true MA44634A1 (fr) 2019-09-30

Family

ID=68426004

Family Applications (1)

Application Number Title Priority Date Filing Date
MA44634A MA44634A1 (fr) 2014-03-14 2014-03-14 Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate

Country Status (1)

Country Link
MA (1) MA44634A1 (fr)

Similar Documents

Publication Publication Date Title
MA38488A1 (fr) Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate
MX2016014306A (es) Marcadores para terapia con lipoproteinas de alta densidad (hdl).
EA201692050A1 (ru) Лечение неалкогольной жировой болезни печени и неалкогольного стеатогепатита
EA201790271A1 (ru) Ингибиторы гликозидазы
PH12017500841B1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
FR3021970B1 (fr) Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
MA38827A1 (fr) Combinaison d'un inhibiteur de mek et d'un inhibiteur d'erk pour l'utilisation dans le traitement de maladies hyperprolifératives
EA201791993A1 (ru) Способы лечения протеинопатий
PH12018501443A1 (en) Methods of administering hepcidin
MX2018002263A (es) Potenciador de atp intracelular.
EA201791021A1 (ru) 1-[2-(АМИНОМЕТИЛ)БЕНЗИЛ]-2-ТИОКСО-1,2,3,5-ТЕТРАГИДРО-4H-ПИРРОЛО[3,2-d]ПИРИМИДИН-4-ОНЫ КАК ИНГИБИТОРЫ МИЕЛОПЕРОКСИДАЗЫ
MX2024000805A (es) Terapias combinadas para la ateroesclerosis, incluyendo la enfermedad cardiovascular ateroesclerotica.
MX2019014306A (es) Agente para reducir la cantidad de proteina beta amiloide.
MA39447A1 (fr) (s)-pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
EA201790315A1 (ru) Модуляторы x-рецепторов печени
MX2016009867A (es) Terapias dirigidas.
MA39448A1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
BR112019001810A2 (pt) composições para limpeza sólidas com taurina e seus métodos
PH12019501358A1 (en) Methods of administering hepcidin
MA44634A1 (fr) Formes de sel de (s)-quinuclidin-3-yl (2-(2-(4-fluorophényl)thiazol-4-yl)propan-2-yl)carbamate
EA201790642A1 (ru) Аллель-специфическая терапия для гаплотипов болезни хантингтона
NZ702645A (en) A method of improving liver function
MX2017000184A (es) Agentes de interaccion enzimatica.
EA201990480A1 (ru) Комбинация обратных агонистов гистамин-3 рецептора с ингибиторами ацетилхолинэстеразы
EA201891739A1 (ru) ПРИМЕНЕНИЕ СТИМУЛЯТОРОВ sGC ДЛЯ ЛЕЧЕНИЯ НЕАЛКОГОЛЬНОГО СТЕАТОГЕПАТИТА (NASH)